Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Viyaasan Mahalingasivam

Research Student - MPhil/PhD - Epidemiology & Population Health

United Kingdom

Jump to: Affiliations Research Publications

I graduated from Barts and The London School of Medicine & Dentistry in 2010 and subsequently completed training in Nephrology and General Internal Medicine on the North Thames rotation in London. I undertook a Masters degree in Epidemiology at the London School of Hygiene & Tropical Medicine in 2017-19, and returned to commence an NIHR Doctoral Research Fellowship in 2021.

 

I am an honorary consultant nephrologist at Barts Health NHS Trust. My clinical interests include chronic kidney disease, adult polycystic kidney disease and haemodialysis.

Affiliations
Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Research

The focus of my Fellowship has been to use electronic health records to investigate long-term kidney outcomes after COVID-19 and the economic effects of the pandemic on kidney care. I primarily work on the OpenSAFELY platform, but have also had the opportunity to undertake complementary research in collaboration with the Stockholm CREAtinine Measurements (SCREAM) project based at the Karolinska Institute in Sweden.

 

My longer term research interest is in the implementation of community-based interventions to address structural inequalities in the management of chronic kidney disease and its risk factors.

Research Area
Electronic health records
Epidemiology
Health economics
Disease and Health Conditions
Kidney disease
COVID-19
Country
United Kingdom

Selected Publications
Clinical codelist - Acute Renal Failure - CPRD Aurum
COSTE, A; MAHALINGASIVAM, V;
2025
London School of Hygiene & Tropical Medicine
Kidney Function Decline After COVID-19 Infection.
MAHALINGASIVAM, V; Faucon, A-L; Sjölander, A; Bosi, A; González-Ortiz, A; Lando, S; Fu, EL; NITSCH, D; Bruchfeld, A; Evans, M; Wing, K; Mansfield, KE; TOMLINSON, L; Carrero, J-J;
2024
JAMA network open
Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform
COSTELLO, R; Waller, K; Smith, R; Mells, G; WONG, A; SCHULTZE, A; MAHALINGASIVAM, V; HERRETT, E; Zheng, B; Lin, L-Y; Mehrkar, A; Bacon, S; Goldacre, B; MacKenna, B; TAZARE, J; Rentsch, PhD, FISPE, C; TOMLINSON, L;
2024
Communications Medicine
Drug use and acute kidney injury: a Drug-Wide Association Study (DWAS) in Denmark and Sweden.
Bosi, A; Lund, LC; MAHALINGASIVAM, V; Mazhar, F; Christiansen, CF; Sjölander, A; Pottegård, A; Carrero, JJ;
2024
Clinical kidney journal
Impacts of the COVID-19 pandemic on deprivation-level differences in cardiovascular hospitalisations: a comparison of England and Denmark using the OpenSAFELY platform and National Registry Data.
COSTELLO, RE; Pedersen, L; Henderson, AD; TAZARE, J; Sorensen, HT; Vandenbroucke, JP; Mansfield, KE; MAHALINGASIVAM, V; Zheng, B; CARREIRA, H; BIDULKA, P; Piehlmaier, DM; WONG, AY S; WARREN-GASH, C; Hayes, JF; Quint, JK; Katikireddi, SV; Mackenna, B; Mehrkar, A; Bacon, S; Goldacre, B; TOMLINSON, LA; LANGAN, SM; Mathur, R; Collaborative, TL W N O C; ... Consortium, TO.
2024
BMJ open
Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY.
Wiedemann, M; Speed, V; Cunningham, C; Higgins, R; Curtis, HJ; Andrews, C; Fisher, L; Hopcroft, L; RENTSCH, CT; MAHALINGASIVAM, V; TOMLINSON, L; Morton, C; Samuel, M; Green, A; Wood, C; Brown, AD; Massey, J; Walters, C; Smith, RM; Inglesby, P; Evans, D; Maude, S; Dillingham, I; Walker, AJ; Morley, J; ... MacKenna, B.
2024
Open heart
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people.
Taylor, K; Eastwood, S; Walker, V; Cezard, G; Knight, R; Al Arab, M; Wei, Y; Horne, EM F; Teece, L; FORBES, H; Walker, A; Fisher, L; Massey, J; Hopcroft, LE M; Palmer, T; Cuitun Coronado, J; Ip, S; Davy, S; Dillingham, I; Morton, C; Greaves, F; Macleod, J; GOLDACRE, B; Wood, A; Chaturvedi, N; ... OpenSAFELY collaborative,
2024
The lancet. Diabetes & endocrinology
Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis.
Henderson, AD; Butler-Cole, BF; Tazare, J; TOMLINSON, LA; MARKS, M; JIT, M; BRIGGS, A; Lin, L-Y; CARLILE, O; Bates, C; Parry, J; Bacon, SC; Dillingham, I; Dennison, WA; COSTELLO, RE; Wei, Y; Walker, AJ; Hulme, W; GOLDACRE, B; Mehrkar, A; MacKenna, B; OpenSAFELY Collaborative,; HERRETT, E; Eggo, RM;
2024
EClinicalMedicine
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT).
CARLILE, O; BRIGGS, A; Henderson, AD; Butler-Cole, BF C; Tazare, J; TOMLINSON, LA; MARKS, M; JIT, M; Lin, L-Y; Bates, C; Parry, J; Bacon, SC J; Dillingham, I; Dennison, WA; COSTELLO, RE; Walker, AJ; Hulme, W; GOLDACRE, B; Mehrkar, A; MacKenna, B; OpenSAFELY Collaborative,; HERRETT, E; EGGO, RM;
2024
The Lancet Regional Health - Europe
Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry.
Santhakumaran, S; Fisher, L; Zheng, B; MAHALINGASIVAM, V; Plumb, L; PARKER, EP; Steenkamp, R; Morton, C; Mehrkar, A; Bacon, S; Lyon, S; Konstant-Hambling, R; GOLDACRE, B; MacKenna, B; TOMLINSON, LA; Nitsch, D;
2024
BMJ medicine
See more information
Viyaasan Mahalingasivam

Contact

United Kingdom